Slide 1C-Reactive Protein: What Is It?  Marker of inflammation made in liver 1  Acute-phase response  Illness or injury 2  Adipocyte release of cytokines may…

1. 2010 ACR/EULAR ClassificationCriteria for Rheumatoid Arthritis 2. Published in the September 2010 Issues of A&R and ARD 3. Phases of the ProjectPhase 1 Phase 2Data…

Slide 1A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein…

Slide 1 JUPITER Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin Ridker P et al. N Eng J Med 2008;359: 2195-2207…

JUPITER Primary Trial End Point: MI, Stroke, UA/Revascularization, CV Death A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently…

Inflammatory Markers, Pharmacotherapy, and Clinical Trials Paul M. Ridker, M.D., M.P.H., and Christie M. Ballantyne, M.D. Is there clinical evidence that inflammation can…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…